Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D&T) Committee Meeting Results for: June 15, 2016

Drugs and Therapeutics (D & T) Committee

Meeting Results

June 15, 2016

Drug Name

Review Type

Committee Recommendation

Prior Approval Status – Final Determination

Dyanavel XR

New Drug Initial Review

Require Prior

Approval

Prior Approval Required

Viberzi

New Drug Initial Review
Require Prior
 Approval
Prior Approval Required

Savaysa

New Drug Appeal
Require Prior
Approval (Non-Preferred)
Prior Approval Required
(Non-Preferred)

Orenitram

New Drug Appeal
Remove from Agenda
Removed from Agenda

Xeljanz

New Drug Appeal
Require Prior
Approval (Non-Preferred)
Prior Approval Required
(Non-Preferred)

Xeljanz XR

New Drug Appeal
Require Prior
Approval (Non-Preferred)
Prior Approval Required
(Non-Preferred)

Brilinta

PDL Appeal

Require Prior Approval

Prior Approval Required